1

XBiotech

#9651

Rank

$71.04M

Marketcap

US United States

Country

XBiotech
Leadership team

Mr. John Simard (Founder, Pres, CEO & Chairman)

Ms. Queena Han B.A., C.G.A., CPA, CPA (VP of Fin. & HR and Sec.)

Dr. Sushma Shivaswamy Ph.D. (Chief Scientific Officer)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
50 - 100
Headquarters
Austin, Texas, United States
Established
2005
Company Registration
SEC CIK number: 0001626878
Revenue
5M - 20M
Traded as
XBIT
Social Media
Overview
Location
Summary
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
History

XBiotech was founded in 2007 by John Simard, a physician-scientist with an entrepreneurial spirit. Headquartered in Austin, Texas, XBiotech has grown to over 200 employees located around the world.

Mission
Our mission is to pioneer marvels of science, transforming healthcare for people around the world.
Vision
We are devoted to unlocking the power of true human antibodies and discovering revolutionary therapies worldwide. By investing in science and the aspects of human life that define the world, we are changing the future of medicine.
Key Team

Mr. Benjamín Guzmán (Sr. VP of Corp. Strategy & Fin.)

Ms. Lisa Simard (Director of Corp. Strategy - XBiotech USA, Inc.)

Recognition and Awards
XBiotech was recognized by FierceBiotech as one of Fierce's Top 15 Private Biotechs in 2014 and chosen as a 'Standout Company' by BioWorld in 2014, among other awards. In 2017, XBiotech was named to the 2017 Forbes Small Giants list.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

XBiotech
Leadership team

Mr. John Simard (Founder, Pres, CEO & Chairman)

Ms. Queena Han B.A., C.G.A., CPA, CPA (VP of Fin. & HR and Sec.)

Dr. Sushma Shivaswamy Ph.D. (Chief Scientific Officer)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
50 - 100
Headquarters
Austin, Texas, United States
Established
2005
Company Registration
SEC CIK number: 0001626878
Revenue
5M - 20M
Traded as
XBIT
Social Media